Orexigen® Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity.

Orexigen’s lead product candidate for the treatment of obesity is Contrave^® (naltrexone Sustained Release (SR)/bupropion SR). Orexigen’s second product candidate for obesity treatment is Empatic™ (zonisamide SR/bupropion SR).

Investor Relations Presentations »